(i) The evolution of the research, given that sometimes there are subsequent findings that are proven uncertain or irreproducible, may reduce the credibility of the CPG recommendations
96
20 (20.8)
5 (5.2)
71 (74.0)
(ii) The complexity of the process recommended in the CPG difficults adherence
96
48 (50.0)
6 (6.3)
42 (43.8)
(iii) Scientific advances organized in the form of guidelines and recommendations are an invaluable help for clinicians
98
2 (2.0)
2 (2.0)
94 (95.9)
(iv) The objective of the guidelines is to provide an up-to-date informative framework that helps the clinician to make the most appropriate decisions individually for each patient
98
3 (3.0)
1 (1.0)
94 (95.9)
(v) The dynamic nature of scientific knowledge implies the periodic reassessment of the CPGs
98
2 (2.0)
0
96 (97.9)
(vi) An effective dissemination of the CPGs and their updates is necessary
98
2 (2.0)
0
96 (97.9)
(vii) There are different CPGs whose recommendations do not coincide
96
13 (13.6)
6 (6.3)
77 (80.2)†
(viii) Although a guide is well implemented it is difficult to maintain it, since after a certain time professionals tend to return to their previous routines
96
66 (68.8)
6 (6.3)
24 (25.0)
(ix) It is crucial to incorporate adherence indicators to the CPGs
96
4 (4.2)
6 (6.3)
86 (89.6)†
(x) The large number of CPGs on diabetes may prevent effective dissemination
96
6 (6.3)
4 (4.2)
86 (89.6)†
Consensus achieved in the first Delphi round; †consensus achieved in the second Delphi round.
